BACKGROUND: Colorectal anastomoses created in a contaminated environment result in a high leakage rate. This study investigated whether using anastomotic sealants (TissuCol(®), Histoacryl(®) Flex, and Duraseal(®)) prevents leakage in a rat peritonitis model. STUDY DESIGN: Sixty-seven Wistar rats were divided into control and experimental groups (TissuCol, Histoacryl, and Duraseal groups). Peritonitis was induced 1 day before surgery with the cecal ligation puncture model. On day 0, colonic anastomosis was constructed with sutures and then sealed with no adhesive (control group) or one select adhesive (experimental groups). Bursting pressure, abscess formation, and adhesion severity were evaluated on day 3 or day 14. Hematoxylin and eosin staining and immunohistochemical staining for CD4, CD8, CD206, and iNOS were performed. RESULTS: On day 3, bursting pressures of the TissuCol group (120.1 ± 25.3 mmHg), Histoacryl group (117.3 ± 20.2 mmHg), and Duraseal group (123.6 ± 35.4 mmHg) were significantly higher than the that of the control group (24.4 ± 31.7 mmHg, p < 0.001). Abscesses around the anastomosis were found in the control group (6/7) and Duraseal group (2/9) but not in the TissuCol group or Histoacryl group. A higher number of CD206+ cells (M2 macrophages), a lower number of iNOS+ cells (M1 macrophages), a higher M2/M1 index, and a higher CD4+/CD8+ index were seen at the anastomotic site in all experimental groups compared with the control group on day 3. On day 14, abscesses were only found in the control group. Adhesion severity in the Duraseal group was significantly lower than that in the control group (p = 0.001). CONCLUSIONS: Anastomotic sealing using TissuCol(®), Histoacryl(®) Flex, or Duraseal(®) seems to be an effective and safe option to prevent leakage in contaminated colorectal surgery. The presence of large numbers of anti-inflammatory macrophages seems to be involved in preventing the leakage.
BACKGROUND: Colorectal anastomoses created in a contaminated environment result in a high leakage rate. This study investigated whether using anastomotic sealants (TissuCol(®), Histoacryl(®) Flex, and Duraseal(®)) prevents leakage in a ratperitonitis model. STUDY DESIGN: Sixty-seven Wistar rats were divided into control and experimental groups (TissuCol, Histoacryl, and Duraseal groups). Peritonitis was induced 1 day before surgery with the cecal ligation puncture model. On day 0, colonic anastomosis was constructed with sutures and then sealed with no adhesive (control group) or one select adhesive (experimental groups). Bursting pressure, abscess formation, and adhesion severity were evaluated on day 3 or day 14. Hematoxylin and eosin staining and immunohistochemical staining for CD4, CD8, CD206, and iNOS were performed. RESULTS: On day 3, bursting pressures of the TissuCol group (120.1 ± 25.3 mmHg), Histoacryl group (117.3 ± 20.2 mmHg), and Duraseal group (123.6 ± 35.4 mmHg) were significantly higher than the that of the control group (24.4 ± 31.7 mmHg, p < 0.001). Abscesses around the anastomosis were found in the control group (6/7) and Duraseal group (2/9) but not in the TissuCol group or Histoacryl group. A higher number of CD206+ cells (M2 macrophages), a lower number of iNOS+ cells (M1 macrophages), a higher M2/M1 index, and a higher CD4+/CD8+ index were seen at the anastomotic site in all experimental groups compared with the control group on day 3. On day 14, abscesses were only found in the control group. Adhesion severity in the Duraseal group was significantly lower than that in the control group (p = 0.001). CONCLUSIONS: Anastomotic sealing using TissuCol(®), Histoacryl(®) Flex, or Duraseal(®) seems to be an effective and safe option to prevent leakage in contaminated colorectal surgery. The presence of large numbers of anti-inflammatory macrophages seems to be involved in preventing the leakage.
Authors: Vasilis A Constantinides; Paris P Tekkis; Thanos Athanasiou; Omer Aziz; Sanjay Purkayastha; Feza H Remzi; Victor W Fazio; Nail Aydin; Ara Darzi; Asha Senapati Journal: Dis Colon Rectum Date: 2006-07 Impact factor: 4.585
Authors: H S Snijders; M W J M Wouters; N J van Leersum; N E Kolfschoten; D Henneman; A C de Vries; R A E M Tollenaar; B A Bonsing Journal: Eur J Surg Oncol Date: 2012-09-03 Impact factor: 4.424
Authors: Zhouqiao Wu; Geesien S A Boersema; Konstantinos A Vakalopoulos; Freek Daams; Cloe L Sparreboom; Gert-Jan Kleinrensink; Johannes Jeekel; Johan F Lange Journal: J Biomed Mater Res B Appl Biomater Date: 2013-10-24 Impact factor: 3.368
Authors: Daniela Dal Secco; Juliane Alves Paron; Sandra H P de Oliveira; Sérgio Henrique Ferreira; João Santana Silva; Fernando de Queiroz Cunha Journal: Nitric Oxide Date: 2003-11 Impact factor: 4.427
Authors: Cloë L Sparreboom; Zhouqiao Wu; Adem Dereci; Geesien S A Boersema; Anand G Menon; Jiafu Ji; Gert-Jan Kleinrensink; Johan F Lange Journal: Gastroenterol Res Pract Date: 2016-03-09 Impact factor: 2.260
Authors: G S A Boersema; Z Wu; L F Kroese; S Vennix; Y M Bastiaansen-Jenniskens; J W van Neck; K H Lam; G J Kleinrensink; J Jeekel; J F Lange Journal: Int J Colorectal Dis Date: 2016-04-04 Impact factor: 2.571
Authors: Dirk Van de Putte; Christelle Demarquay; Elke Van Daele; Lara Moussa; Christian Vanhove; Marc Benderitter; Wim Ceelen; Piet Pattyn; Noëlle Mathieu Journal: Cell Transplant Date: 2017-12 Impact factor: 4.064